Your browser doesn't support javascript.
The mental health burden of racial and ethnic minorities during the COVID-19 pandemic.
Nguyen, Long H; Anyane-Yeboa, Adjoa; Klaser, Kerstin; Merino, Jordi; Drew, David A; Ma, Wenjie; Mehta, Raaj S; Kim, Daniel Y; Warner, Erica T; Joshi, Amit D; Graham, Mark S; Sudre, Carole H; Thompson, Ellen J; May, Anna; Hu, Christina; Jørgensen, Solveig; Selvachandran, Somesh; Berry, Sarah E; David, Sean P; Martinez, Maria Elena; Figueiredo, Jane C; Murray, Anne M; Sanders, Alan R; Koenen, Karestan C; Wolf, Jonathan; Ourselin, Sebastien; Spector, Tim D; Steves, Claire J; Chan, Andrew T.
  • Nguyen LH; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States of America.
  • Anyane-Yeboa A; Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States of America.
  • Klaser K; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, United States of America.
  • Merino J; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States of America.
  • Drew DA; Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States of America.
  • Ma W; School of Biomedical Engineering & Imaging Sciences, King's College London, London, United Kingdom.
  • Mehta RS; Diabetes Unit and Center for Genomic Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States of America.
  • Kim DY; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States of America.
  • Warner ET; Broad Institute of MIT and Harvard, Cambridge, MA, United States of America.
  • Joshi AD; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States of America.
  • Graham MS; Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States of America.
  • Sudre CH; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States of America.
  • Thompson EJ; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, United States of America.
  • May A; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States of America.
  • Hu C; Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States of America.
  • Jørgensen S; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, United States of America.
  • Selvachandran S; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States of America.
  • Berry SE; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States of America.
  • David SP; Department of Twin Research and Genetic Epidemiology, King's College London, London, United Kingdom.
  • Martinez ME; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States of America.
  • Figueiredo JC; School of Biomedical Engineering & Imaging Sciences, King's College London, London, United Kingdom.
  • Murray AM; School of Biomedical Engineering & Imaging Sciences, King's College London, London, United Kingdom.
  • Sanders AR; Harvard/MGH Center on Genomics, Vulnerable Populations, and Health Disparities, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States of America.
  • Koenen KC; Zoe Ltd, London, United Kingdom.
  • Wolf J; Zoe Ltd, London, United Kingdom.
  • Ourselin S; Zoe Ltd, London, United Kingdom.
  • Spector TD; Zoe Ltd, London, United Kingdom.
  • Steves CJ; Department of Nutritional Sciences, King's College London, London, United Kingdom.
  • Chan AT; Department of Family Medicine, University of Chicago, Evanston, IL, United States of America.
PLoS One ; 17(8): e0271661, 2022.
Article in English | MEDLINE | ID: covidwho-1987153
ABSTRACT
Racial/ethnic minorities have been disproportionately impacted by COVID-19. The effects of COVID-19 on the long-term mental health of minorities remains unclear. To evaluate differences in odds of screening positive for depression and anxiety among various racial and ethnic groups during the latter phase of the COVID-19 pandemic, we performed a cross-sectional analysis of 691,473 participants nested within the prospective smartphone-based COVID Symptom Study in the United States (U.S.) and United Kingdom (U.K). from February 23, 2021 to June 9, 2021. In the U.S. (n=57,187), compared to White participants, the multivariable odds ratios (ORs) for screening positive for depression were 1·16 (95% CI 1·02 to 1·31) for Black, 1·23 (1·11 to 1·36) for Hispanic, and 1·15 (1·02 to 1·30) for Asian participants, and 1·34 (1·13 to 1·59) for participants reporting more than one race/other even after accounting for personal factors such as prior history of a mental health disorder, COVID-19 infection status, and surrounding lockdown stringency. Rates of screening positive for anxiety were comparable. In the U.K. (n=643,286), racial/ethnic minorities had similarly elevated rates of positive screening for depression and anxiety. These disparities were not fully explained by changes in leisure time activities. Racial/ethnic minorities bore a disproportionate mental health burden during the COVID-19 pandemic. These differences will need to be considered as health care systems transition from prioritizing infection control to mitigating long-term consequences.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Humans Country/Region as subject: North America Language: English Journal: PLoS One Journal subject: Science / Medicine Year: 2022 Document Type: Article Affiliation country: Journal.pone.0271661

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Humans Country/Region as subject: North America Language: English Journal: PLoS One Journal subject: Science / Medicine Year: 2022 Document Type: Article Affiliation country: Journal.pone.0271661